Gilli Haskel-Galore
Ramat Gan, TA 52626, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Anti-4CB1: A Novel Selective HVEM-Blocking Antibody Enhancing T-Cell and Macrophage Immunity Against Solid Tumors.
Journal: Molecular cancer therapeutics
Published: November 27, 2025
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.
Journal: Cancer immunology research
Published: August 17, 2021
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: April 25, 2020
Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma.
Journal: Oncotarget
Published: April 12, 2017
CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis.
Journal: Oncotarget
Published: October 03, 2015
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme.
Journal: Oncotarget
Published: May 19, 2015
Highlights from the latest articles in pharmacogenomics research.
Journal: Pharmacogenomics
Published: August 02, 2014
CEACAM1 promotes melanoma cell growth through Sox-2.
Journal: Neoplasia (New York, N.Y.)
Published: June 17, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026